The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Aldactone 100 mg Film-coated tablets

100 milligram(s) Film-coated tablet

Pfizer Healthcare IrelandPA0822/110/003

Main Information

Trade NameAldactone 100 mg Film-coated tablets
Active SubstancesSpironolactone
Strength100 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderPfizer Healthcare Ireland
Licence NumberPA0822/110/003

Group Information

ATC CodeC03DA Aldosterone antagonists
C03DA01 spironolactone

Status

Authorised/WithdrawnAuthorised
Licence Issued13/03/1975
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceNone
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back